1. Bray, F, Ferlay, J, Soerjomataram, I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinicians 2018; 68: 394–424.
Google Scholar | Crossref | Medline2. Mnejja, W, Daoud, H, Fourati, N, et al. Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma. Rep Pract Oncol Radiother 2020; 25: 41–45.
Google Scholar | Crossref | Medline3. Lei, F, Lei, T, Huang, Y, et al. Radio-susceptibility of nasopharyngeal carcinoma: focus on epstein- barr virus, microRNAs, long non-coding RNAs and circular RNAs. Curr Mol Pharmacol 2020; 13: 192–205.
Google Scholar | Crossref | Medline4. National Comprehensive Cancer Network . Head and Neck Cancers, 2019, https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf (accessed 1 March 2020). version 3.
Google Scholar5. Yan, D-F, Zhang, W-B, Ke, S-B, et al. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma. BMC Cancer 2017; 17: 678.
Google Scholar | Crossref | Medline6. Wang, L, Guo, Y, Xu, J, et al. Clinical analysis of recurrence patterns in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Ann Otology, Rhinology Laryngol 2017; 126: 789–797.
Google Scholar | SAGE Journals | ISI7. Jin, Y-N, Yao, J-J, Zhang, F, et al. Is pretreatment Epstein-Barr virus DNA still associated with 6-year survival outcomes in locoregionally advanced nasopharyngeal carcinoma? J Cancer 2017; 8: 976–982.
Google Scholar | Crossref | Medline8. Cho, J-K, Lee, G-J, Yi, K-I, et al. Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients. Eur J Cancer 2015; 51: 1303–1311.
Google Scholar | Crossref | Medline9. Zou, X, Han, F, Ma, W-J, et al. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma. Head & Neck 2015; 37: 1108–1115.
Google Scholar | Crossref | Medline10. Hsiung, C-Y, Yorke, ED, Chui, C-S, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncology*Biology*Physics 2002; 53: 638–647.
Google Scholar | Crossref | Medline | ISI11. Liu, Y, Long, W, Wang, G, et al. Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma. Cancer Med 2020; 9: 1328–1334.
Google Scholar | Crossref | Medline12. Ng, S-H, Liu, H-M, Ko, S-F, et al. Posttreatment imaging of the nasopharynx. Eur J Radiol 2002; 44: 82–95.
Google Scholar | Crossref | Medline13. Thoeny, HC, De Keyzer, F, King, AD. Diffusion-weighted MR imaging in the head and neck. Radiology 2012; 263: 19–32.
Google Scholar | Crossref | Medline | ISI14. Padhani, AR, Liu, G, Mu-Koh, D, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102–125.
Google Scholar | Crossref | Medline | ISI15. Wang, J, Takashima, S, Takayama, F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001; 220: 621–630.
Google Scholar | Crossref | Medline | ISI16. Lai, V, Khong, PL. Updates on MR imaging and 18F-FDG PET/CT imaging in nasopharyngeal carcinoma. Oral Oncol 2014; 50: 539–548.
Google Scholar | Crossref | Medline17. Chen, Y, Liu, X, Zheng, D, et al. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 2014; 32: 630–637.
Google Scholar | Crossref | Medline18. Hong, J, Yao, Y, Zhang, Y, et al. Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma. Otolaryngology-Head Neck Surg 2013; 149: 707–713.
Google Scholar | SAGE Journals | ISI19. Vandecaveye, V, Dirix, P, De Keyzer, F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010; 20: 1703–1714.
Google Scholar | Crossref | Medline | ISI20. Galbán, CJ, Mukherji, SK, Chenevert, TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Translational Oncol 2009; 2: 184–190.
Google Scholar | Crossref | Medline | ISI21. Hou, J, Yu, X, Hu, Y, et al. Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma. Medicine 2016; 95: e4320.
Google Scholar | Crossref | Medline22. Zhang, GY, Wang, YJ, Liu, JP, et al. Pretreatment diffusion-weighted MRI can predict the response to neoadjuvant chemotherapy in patients with nasopharyngeal carcinoma. Biomed Research International 2015; 2015: 307943.
Google Scholar | Medline23. King, AD, Chow, K-K, Yu, K-H, et al. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013; 266: 531–538.
Google Scholar | Crossref | Medline | ISI24. Hatakenaka, M, Shioyama, Y, Nakamura, K, et al. Apparent diffusion coefficient calculated with relatively high b-values correlates with local failure of head and neck squamous cell carcinoma treated with radiotherapy. Am J Neuroradiology 2011; 32: 1904–1910.
Google Scholar | Crossref | Medline25. King, AD, Mo, FKF, Yu, K-H, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010; 20: 2213–2220.
Google Scholar | Crossref | Medline26. Kim, S, Loevner, L, Quon, H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009; 15: 986–994.
Google Scholar | Crossref | Medline | ISI27. Wei, KR, Xu, Y, Liu, J, et al. Histopathological classification of nasopharyngeal carcinoma. Asian Pac Journal Cancer Prevention : APJCP 2011; 12: 1141–1147.
Google Scholar | Medline28. Lertbutsayanukul, C, Kannarunimit, D, Netsawang, B, et al. Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy. Jpn J Clin Oncol 2018; 48: 467–475.
Google Scholar | Crossref | Medline29. Eisenhauer, EA, Therasse, P, Bogaerts, J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–247.
Google Scholar | Crossref | Medline | ISI30. Thoeny, HC, De Keyzer, F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007; 17: 1385–1393.
Google Scholar | Crossref | Medline | ISI31. Ross, BD, Moffat, BA, Lawrence, TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Therapeutics 2003; 2: 581–587.
Google Scholar | Medline | ISI32. Peng, H, Huang, Q, Yue, H, et al. The antitumor effect of cisplatin-loaded thermosensitive chitosan hydrogel combined with radiotherapy on nasopharyngeal carcinoma. Int J Pharmaceutics 2019; 556: 97–105.
Google Scholar | Crossref | Medline33. Huang, SH, O’Sullivan, B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 2017; 18: 40.
Google Scholar | Crossref | Medline